These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18170839)

  • 1. VITREOUS HAEMORRHAGE AFTER "ROVACICLINA".
    Busacca A
    Br J Ophthalmol; 1962 Nov; 46(11):703. PubMed ID: 18170839
    [No Abstract]   [Full Text] [Related]  

  • 2. [Toxoplasmosis retinochorioiditis, a therapy comparison between spiramycin and pyrimethamine/sulfadiazine].
    Hacker M; Richter R; Gümbel H; Richter T; Ohrloff C
    Klin Monbl Augenheilkd; 1998 Feb; 212(2):84-7. PubMed ID: 9577806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spiramycin-associated acute dystonia during neuroleptic treatment.
    Benazzi F
    Can J Psychiatry; 1997 Aug; 42(6):665-6. PubMed ID: 9288434
    [No Abstract]   [Full Text] [Related]  

  • 4. Acquired ocular toxoplasmosis in pregnancy.
    Ramchandani M; Weaver JB; Joynson DH; Murray PI
    Br J Ophthalmol; 2002 Aug; 86(8):938-9. PubMed ID: 12140226
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of ocular toxoplasmosis with spiramycin.
    CHODOS JB; HABEGGER-CHODOS HE
    Arch Ophthalmol; 1961 Mar; 65():401-9. PubMed ID: 13693235
    [No Abstract]   [Full Text] [Related]  

  • 6. Spiramycin-related cutaneous eruption confirmed by patch testing.
    Poveda-Montoyo I; Álvarez-Chinchilla PJ; García Del Pozo MC; Encabo B; Silvestre JF
    Contact Dermatitis; 2018 Mar; 78(3):233-234. PubMed ID: 29430709
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of ocular toxoplasmosis. Part 2: Therapeutic approaches].
    Mittelviefhaus H
    Kinderarztl Prax; 1993 Jun; 61(4-5):154-60. PubMed ID: 8361145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spiramycin-induced liver injury.
    Saab YB; Mroueh MA
    Ann Pharmacother; 2002 Dec; 36(12):1972. PubMed ID: 12452764
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acute cholestatic hepatitis induced by spiramycin].
    Zuazo JA; Revuelta C; Pérez Alvarez JC; López Morante A; Sáez-Royuela F
    Gastroenterol Hepatol; 1997 Nov; 20(9):474-5. PubMed ID: 9445745
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypersensitivity to spiramycin with good tolerance of other macrolides.
    Sánchez-Morillas L; Laguna-Martínez JJ; Reaño-Martos M; Rojo-Andrés E; Gómez-Tembleque P; Santaolalla-Montoya M
    J Investig Allergol Clin Immunol; 2007; 17(6):417-8. PubMed ID: 18088029
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute generalized exanthematic pustulosis induced by spiramycin : usefulness of patch testing.
    Kastalli S; Charfi O; El Aïdli S; Zaïem A; Daghfous R
    Tunis Med; 2016 Jul; 94(7):339. PubMed ID: 28051238
    [No Abstract]   [Full Text] [Related]  

  • 12. Oxidative haemolysis after spiramycin.
    Sarma PS
    Postgrad Med J; 1997 Oct; 73(864):686-7. PubMed ID: 9497998
    [No Abstract]   [Full Text] [Related]  

  • 13. Side effects of spiramycin masquerading as local anesthetic toxicity during labor epidural analgesia.
    Julliac B; Théophile H; Begorre M; Richez B; Haramburu F
    Int J Obstet Anesth; 2010 Jul; 19(3):331-2. PubMed ID: 20627689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Spiramycin (rovamycin) in treatment of infections in children and adults].
    Fomina IP; Smirnova LB
    Antibiot Khimioter; 2001; 46(3):29-36. PubMed ID: 11548279
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug Interaction between Sutent (sunitinib) and Bi-spirogyl (spiramycin-metronidazol): risk of toxicity].
    Trabelsi S; Boussen H; Gaïes E; Salouage I; El Aïdli S; Daghfous R; Loueslati MH; Lakhal M; Belkahia C
    Therapie; 2008; 63(6):475-6. PubMed ID: 19374036
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intraocular penetration of 7 drugs with therapeutic effect on toxoplasmosis].
    Tassignon MJ; Brihaye M; De Meuter F; Vercruysse A; Van Hoff F; Merckaert I
    Ophtalmologie; 1987; 1(4):551-6. PubMed ID: 3153942
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment difficulties in ocular toxoplasmosis].
    Stanila A; Popa DE
    Oftalmologia; 2003; 56(1):40-4. PubMed ID: 12886681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [TREATMENT OF TOXOPLASMOSIS. (EXPERIMENTAL STUDY)].
    FRANCOIS J; JADIN J; WERY M; VANDECASTEELE J
    Bull Soc Belge Ophtalmol; 1963; 134():354-61. PubMed ID: 14105007
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe hepatotoxicity associated with the combination of spiramycin plus metronidazole.
    Hussein R; El-Halabi M; Ghaith O; Jurdi N; Azar C; Mansour N; Sharara AI
    Arab J Gastroenterol; 2011 Mar; 12(1):44-7. PubMed ID: 21429456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetracycline/doxycycline-induced cutaneous depressed pigmentation.
    Adişen E; Gürer MA; Erdem O
    Int J Dermatol; 2006 Oct; 45(10):1245-7. PubMed ID: 17040455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.